Last deal

$81M

Amount

Series B

Stage

17.06.2024

Date

1

all rounds

$81M

Total amount

General

About Company
Sfunga Therapeutics develops treatments for life-threatening fungal infections.

Industry

Sector :

Subsector :

Keywords :

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Sfunga Therapeutics is a research and development company that focuses on systemic and life-threatening fungal infections.
Contacts